Erwin Loh: Primary Prevention of Cardiovascular Events With Evolocumab in High-Risk Patients With Diabetes
Erwin Loh, Director of Medical Services at Peninsula Private Hospital, Ramsay Health Care, President at Royal Australasian College of Medical Administrators, shared a post on LinkedIn about a recent article by Nicholas A. Marston et al, adding:
“Targeted cholesterol-lowering therapy can prevent first heart attack or stroke in high-risk patients with diabetes
Researchers found that the intensive cholesterol‑lowering therapy evolocumab reduced the risk of a first major cardiovascular event in high‑risk patients who did not have known atherosclerosis (the build-up of plaque inside artery walls) but did have diabetes.
Results were presented at the American College of Cardiology’s Annual Scientific Session and Expo and simultaneously published in JAMA.”
Title: Evolocumab to Reduce First Major Cardiovascular Events in Patients Without Known Significant Atherosclerosis and With Diabetes
Authors: Nicholas A. Marston, Erin A. Bohula, Ajay K. Bhatia, Gaetano M. De Ferrari, Lawrence A. Leiter, Jose C. Nicolau, Jeong-Gun Park, Sabina A. Murphy, Emileigh Walsh, Lyrica Liu, Subodh Verma, Naveed Sattar, Stephen J. Nicholls, Jose Lopez-Sendon, Ioanna Gouni-Berthold, Lale Tokgozoglu, Ron Blankstein, Marcoli Cyrille, Gabriel Paiva da Silva Lima, Robert P. Giugliano, Marc S. Sabatine
Read the Full Article on JAMA.
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 30, 2026, 14:11Chokri Ben Lamine: Strategic Decision Making in Hematology under Competing Risks
-
Mar 30, 2026, 13:59David McIntosh: How European Plasma Policy Shapes Global Access to Life-Saving Therapies
-
Mar 30, 2026, 13:27Stephanie A. Haddad: Improving Access in Fertility Preservation for AYA Hematology/Oncology Patients
-
Mar 29, 2026, 16:17Ammara Mushtaq: How Research Fills the Gaps in Fast Paced Healthcare
-
Mar 29, 2026, 16:16Pete Stibbs: Insights from the 32nd World Congress of the International Union of Angiology
-
Mar 29, 2026, 16:15Davide Capodanno: Independent Investigators Lead the First Head to Head DOAC Comparison
-
Mar 29, 2026, 16:14James Crowley: Fibrosis Can Be Caused by Mechanical Disruption of the Lymphatic Vessels Alone
-
Mar 29, 2026, 16:02Omar Adwan: Understanding Clinical Significance and Diagnostic Implications of Acanthocytes
-
Mar 29, 2026, 16:01Ifeanyichukwu Ifechidere: Direct Oral Anticoagulants Broke Traditional Coag Testing